Recent publications

Novel anti-malarial agents

IDBI member Marvin Meyers recently published a study on the identification of novel chemotypes with antimalarial efficacy to combat the rise of Plasmodium species resistant to current antimalarial drugs. They used a hybrid target-phenotype approach to identify and evaluate the 4-aryl- N-benzylpyrrolidine-3-carboxamide chemotype as a promising novel chemotype for development into new therapeutics for treatment of malaria